Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Interim Report Q2 2017: Another strong quarter with strong launch of ReSound LiNX 3D


Posted on: 17 Aug 17
  • GN Store Nord delivered 15% revenue growth in Q2 2017 driven by strong performance across GN Hearing and GN Audio. Organic growth was 7%
  • EBITA increased 15% in Q2 2017. The EBITA margin was stable reflecting product launch costs in both businesses and investments in growth as part of the 2017 – 2019 strategy
  • EPS increased 25% and reached DKK 1.92
  • Continued strong cash conversion at 89% in Q2 2017
  • The financial guidance for 2017 is confirmed
  • GN Hearing’s revenue increased 12% in Q2 2017. Organic growth was 5%, on a tough comparison base
  • The newly launched ReSound LiNX 3D generating strong momentum. Double digit organic growth since launch
  • EBITA increased 7% to DKK 255 million. EBITA margin decreased in the quarter reflecting product launch costs and investments in growth as part of the 2017 – 2019 strategy
  • Free cash flow excl. M&A was DKK 267 million in Q2 2017 – an increase of DKK 27 million in H1 2017 compared to H1 2016
  • GN Audio delivered 19% revenue growth in Q2 2017. Organic growth was 12%
  • The continued strong growth was also in Q2 2017 driven by the Jabra Evolve and Jabra Speak series as well as the Jabra Elite Sport true wireless earbuds. The recently launched products have been received exceptionally well by the market
  • EBITA increased 46% and reached DKK 168 million in Q2 2017. EBITA margin increased to 17.2%, driven by favorable product mix and operational leverage
  • Free cash flow excl. M&A was DKK 131 million in Q2 2017 – an increase of DKK 20 million in H1 2017 compared to H1 2016

Quotes from the executive management

Anders Hedegaard, CEO of GN Hearing: “End of April, we launched our 5th generation 2.4 GHz hearing aid family, ReSound LiNX 3D. The strong momentum generated by our new products, as well as the excellent user feedback, sets the stage for a strong second half of 2017. I am very pleased that our continuous focus on innovation is paying off for our users, so that they are now able to hear more, do more and be more than what they ever thought possible.”

René Svendsen-Tune, CEO of GN Audio: “In Q2 2017, we continued to deliver strong results across regions and channels, in line with our 2017 – 2019 strategy. Our strong momentum is the result of our tireless efforts to stay on top of competition through focus on innovation, commercialization and people excellence. I am very pleased to see that our focus has led to both strong topline and bottom line growth.”

Teleconference
GN will host a teleconference at 11.00 am CEST today. Please visit www.gn.com/investor to access the teleconference. Presentation material will be available on the website approximately one hour prior to the teleconference.

For further information please contact:

Peter Justesen
VP – Investor Relations & Treasury
GN Store Nord A/S
Tel: +45 45 75 87 16

or

Rune Sandager
Treasury Manager – Investor Relations & Treasury
GN Store Nord A/S
Tel: +45 45 75 92 57

GlobeNewswire
globenewswire.com

Last updated on: 17/08/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.